McKesson rises after raising annual profit forecast

McKesson

04/02/2026 22:39

** Shares of U.S. drug distributor McKesson MCK.N up 2% at $837.96 after the bell

** MCK raises annual profit forecast, betting on strong growth in its oncology and specialty drug distribution businesses

** Expects annual adjusted EPS in the range of $38.80 to $39.20, compared to its previous outlook of $38.35 to $38.85

** Posts Q3 revenue of $106.16 billion, compared to expectations of $105.86 billion — data compiled by LSEG

** Reports quarterly adjusted EPS of $9.34, beating analysts' estimates of $9.22

** Stock rose 43% in 2025

(Reporting by Koyena Das in Bengaluru)

((koyena.das@thomsonreuters.com))